About Dimzang

Understanding biology differently.

A Ghanaian health technology and biotechnology company working at the intersection of AI, digital health and biological research.

Why we exist

Biology, in context.

Too often, biology is read in fragments: data sits in separate systems, results arrive without context and the chance to act early is lost. Dimzang was created to bring biological information into a clearer, more interpretable form.

That work begins with better detection and extends toward a deeper understanding of how biological systems may recover, adapt and restore.

Our direction

Detect Early. Restore Fully.

Detection: understanding biological change earlier through longitudinal interpretation.

Restoration: exploring how biological systems may regain function and regenerative capacity.

Our Approach

Our team

Meet the team.

Researchers, engineers and operators building Dimzang from Accra and the diaspora.

Portrait of Abraham Nelson Dimzang

Abraham Nelson Dimzang

Founder & CEO

Regenerative medicine research and healthcare systems vision

Portrait of Ella Peprah Boateng

Ella Peprah Boateng

Head of Administration

Operations and organizational coordination

Portrait of Shadrack K. Addo

Shadrack Kwasi Addo

Chief Technology Officer

EDDS architecture and software development

Portrait of Francis Lomo

Francis Lomo

Partnerships & External Relations

Partnerships and external relations

Portrait of Eugenia Hansen

Eugenia Hansen

Research Associate

Biological sciences and laboratory exposure, Noguchi Memorial

Portrait of Faith A. Smith

Faith A. Smith

Diaspora Research Collaborator

Biochemistry and scientific collaboration support

Portrait of Evangel Yorke Acquay

Evangel Yorke Acquay

Legal & Privacy Advisor

Legal and privacy guidance

Where we're rooted

Why Ghana.

Local context, global questions

We work from Ghana with a view toward practical, inclusive and globally relevant health innovation, shaped by local realities and aimed at wider scientific and clinical conversations.

Serious and early

We keep a clear line between what is established, what we propose and what still needs validation. We don't turn research into medical claims.